.png){kind=icon}
Return
Exenatide
.png){kind=icon}
PRE
AI
DOI：10.1038/nrd1828.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En
Keywords:
GLYCEMIC CONTROL
TREATED PATIENTS
EXENDIN-4
SULFONYLUREA
METFORMIN
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
101.8
Papers:
5.1K
Citations:
5.3W
Organization
No organization information available
Cited Papers
Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea.png)
DIABETES CARE
OAAI
DIABETES CAREIF16.6
OAAIShareSaveShareSaveEffects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetesDIABETES CAREOAAI
DIABETES CAREIF16.6
OAAIShareSaveTuning the structure of non-equilibrium soft materials by varying the thermodynamic driving force for crystal orderingSoft MatterOAAI
Soft MatterIF0
OAAIShareSaveEffects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetesDIABETES CARE
DIABETES CAREIF16.6
PREAI
ShareSave no more
no more